Listen: Health equity ‘tourism,’ an $11B biopharma acquisition, & a bony Covid protest
An $11 billion biopharma acquisition. Health equity “tourism.” And, where can you buy a 12-foot pyramid of bones?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we welcome STAT reporter Usha Lee McFarling onto the podcast to discuss her investigation into health equity tourism — how white scholars are colonizing research on health disparities. Then, we “chatty Cathy” a blizzard of biotech news from this week, including Merck’s $11 billion acquisition of Acceleron Pharma, a theatrical street protest about the Covid vaccine equity dive, a debate about gene therapy’s future, and, finally, why Scott Gottlieb is looking up at Elvira.
